BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24297165)

  • 21. Profiling Anti-Neu5Gc IgG in Human Sera with a Sialoglycan Microarray Assay.
    Leviatan Ben-Arye S; Yu H; Chen X; Padler-Karavani V
    J Vis Exp; 2017 Jul; (125):. PubMed ID: 28745644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The glycoimmune checkpoint receptor Siglec-7 interacts with T-cell ligands and regulates T-cell activation.
    Stewart N; Daly J; Drummond-Guy O; Krishnamoorthy V; Stark JC; Riley NM; Williams KC; Bertozzi CR; Wisnovsky S
    J Biol Chem; 2024 Feb; 300(2):105579. PubMed ID: 38141764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Overview of the Importance and Value of Porcine Species in Sialic Acid Research.
    Ogun OJ; Thaller G; Becker D
    Biology (Basel); 2022 Jun; 11(6):. PubMed ID: 35741423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human species-specific loss of CMP-
    Kawanishi K; Dhar C; Do R; Varki N; Gordts PLSM; Varki A
    Proc Natl Acad Sci U S A; 2019 Aug; 116(32):16036-16045. PubMed ID: 31332008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developmental changes in the level of free and conjugated sialic acids, Neu5Ac, Neu5Gc and KDN in different organs of pig: a LC-MS/MS quantitative analyses.
    Ji S; Wang F; Chen Y; Yang C; Zhang P; Zhang X; Troy FA; Wang B
    Glycoconj J; 2017 Feb; 34(1):21-30. PubMed ID: 27613535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism of vertebrate amino sugars with N-glycolyl groups: resistance of α2-8-linked N-glycolylneuraminic acid to enzymatic cleavage.
    Davies LR; Pearce OM; Tessier MB; Assar S; Smutova V; Pajunen M; Sumida M; Sato C; Kitajima K; Finne J; Gagneux P; Pshezhetsky A; Woods R; Varki A
    J Biol Chem; 2012 Aug; 287(34):28917-31. PubMed ID: 22692207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD22 and Siglec-G regulate inhibition of B-cell signaling by sialic acid ligand binding and control B-cell tolerance.
    Nitschke L
    Glycobiology; 2014 Sep; 24(9):807-17. PubMed ID: 25002414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of multifold modified sialosides as human CD22/Siglec-2 ligands with nanomolar activity on B-cells.
    Prescher H; Schweizer A; Kuhfeldt E; Nitschke L; Brossmer R
    ACS Chem Biol; 2014 Jul; 9(7):1444-50. PubMed ID: 24807582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of Siglec expression on T lymphocytes during human evolution.
    Nguyen DH; Hurtado-Ziola N; Gagneux P; Varki A
    Proc Natl Acad Sci U S A; 2006 May; 103(20):7765-70. PubMed ID: 16682635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dendritic cell-dependent inhibition of B cell proliferation requires CD22.
    Santos L; Draves KE; Boton M; Grewal PK; Marth JD; Clark EA
    J Immunol; 2008 Apr; 180(7):4561-9. PubMed ID: 18354178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific Detection of Neu5Gc in Animal Tissues by Immunohistochemistry.
    Paul A; Bachar Abramovitch S; Padler-Karavani V
    Methods Mol Biol; 2020; 2110():59-72. PubMed ID: 32002901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-affinity ligand probes of CD22 overcome the threshold set by cis ligands to allow for binding, endocytosis, and killing of B cells.
    Collins BE; Blixt O; Han S; Duong B; Li H; Nathan JK; Bovin N; Paulson JC
    J Immunol; 2006 Sep; 177(5):2994-3003. PubMed ID: 16920935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of natural human antibodies against a nonhuman sialic acid that metabolically incorporates into activated and malignant immune cells.
    Nguyen DH; Tangvoranuntakul P; Varki A
    J Immunol; 2005 Jul; 175(1):228-36. PubMed ID: 15972653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study on the regulation of N-glycoloylneuraminic acid biosynthesis and utilization in rat and mouse liver.
    Lepers A; Shaw L; Schneckenburger P; Cacan R; Verbert A; Schauer R
    Eur J Biochem; 1990 Nov; 193(3):715-23. PubMed ID: 2249689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modifications of cell surface sialic acids modulate cell adhesion mediated by sialoadhesin and CD22.
    Kelm S; Schauer R; Manuguerra JC; Gross HJ; Crocker PR
    Glycoconj J; 1994 Dec; 11(6):576-85. PubMed ID: 7696861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of B cell development and B cell signalling by CD22 and its ligands alpha2,6-linked sialic acids.
    Ghosh S; Bandulet C; Nitschke L
    Int Immunol; 2006 Apr; 18(4):603-11. PubMed ID: 16497829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single N-linked glycosylation site is implicated in the regulation of ligand recognition by the I-type lectins CD22 and CD33.
    Sgroi D; Nocks A; Stamenkovic I
    J Biol Chem; 1996 Aug; 271(31):18803-9. PubMed ID: 8702538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling.
    Crocker PR
    Curr Opin Struct Biol; 2002 Oct; 12(5):609-15. PubMed ID: 12464312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Localization of the putative sialic acid-binding site on the immunoglobulin superfamily cell-surface molecule CD22.
    van der Merwe PA; Crocker PR; Vinson M; Barclay AN; Schauer R; Kelm S
    J Biol Chem; 1996 Apr; 271(16):9273-80. PubMed ID: 8621588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ligand Recognition Determines the Role of Inhibitory B Cell Co-receptors in the Regulation of B Cell Homeostasis and Autoimmunity.
    Tsubata T
    Front Immunol; 2018; 9():2276. PubMed ID: 30333834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.